A detailed history of Macquarie Group LTD transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Macquarie Group LTD holds 1,831,316 shares of EW stock, worth $123 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,831,316
Previous 1,866,359 1.88%
Holding current value
$123 Million
Previous $178 Million 5.15%
% of portfolio
0.2%
Previous 0.2%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$84.3 - $94.31 $2.95 Million - $3.3 Million
-35,043 Reduced 1.88%
1,831,316 $169 Million
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $9.71 Million - $12.8 Million
-133,921 Reduced 6.7%
1,866,359 $178 Million
Q4 2023

Feb 14, 2024

SELL
$61.71 - $77.76 $2.12 Million - $2.68 Million
-34,431 Reduced 1.69%
2,000,280 $153 Million
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $22.7 Million - $30.6 Million
328,211 Added 19.23%
2,034,711 $141 Million
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $1.58 Million - $1.83 Million
19,440 Added 1.15%
1,706,500 $161 Million
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $44.9 Million - $51.1 Million
-605,178 Reduced 26.4%
1,687,060 $140 Million
Q4 2022

Feb 21, 2023

BUY
$68.3 - $87.44 $14.2 Million - $18.2 Million
208,090 Added 9.98%
2,292,238 $171 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $53.9 Million - $70.2 Million
653,969 Added 45.73%
2,084,148 $172 Million
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $11.8 Million - $17.5 Million
-136,134 Reduced 8.69%
1,430,179 $136 Million
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $10.9 Million - $13.7 Million
-106,921 Reduced 6.39%
1,566,313 $184 Million
Q4 2021

Feb 11, 2022

SELL
$106.37 - $130.68 $3.99 Million - $4.9 Million
-37,524 Reduced 2.19%
1,673,234 $217 Million
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $17.1 Million - $20.4 Million
-166,487 Reduced 8.87%
1,710,758 $194 Million
Q2 2021

Aug 13, 2021

BUY
$83.84 - $104.76 $21.6 Million - $27 Million
257,857 Added 15.92%
1,877,245 $194 Million
Q1 2021

May 14, 2021

SELL
$78.68 - $90.67 $8.25 Million - $9.51 Million
-104,912 Reduced 6.08%
1,619,388 $135 Million
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $18.2 Million - $23.2 Million
254,030 Added 17.28%
1,724,300 $157 Million
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $78.1 Million - $102 Million
1,162,530 Added 377.76%
1,470,270 $117 Million
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $11.6 Million - $15.5 Million
201,835 Added 190.58%
307,740 $21.3 Million
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $406,911 - $628,884
-7,764 Reduced 6.83%
105,905 $20 Million
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $5.58 Million - $6.39 Million
77,855 Added 217.39%
113,669 $26.5 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $186,434 - $228,477
-3,029 Reduced 7.8%
35,814 $7.88 Million
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $153,006 - $176,805
-2,745 Reduced 6.6%
38,843 $7.18 Million
Q1 2019

May 15, 2019

SELL
$47.89 - $64.05 $777,542 - $1.04 Million
-16,236 Reduced 28.08%
41,588 $7.96 Million
Q4 2018

Feb 15, 2019

SELL
$46.41 - $56.94 $226,016 - $277,297
-4,870 Reduced 7.77%
57,824 $8.86 Million
Q3 2018

Nov 15, 2018

BUY
$45.7 - $58.03 $436,435 - $554,186
9,550 Added 17.97%
62,694 $10.9 Million
Q2 2018

Aug 14, 2018

SELL
$42.45 - $51.3 $126,034 - $152,309
-2,969 Reduced 5.29%
53,144 $7.74 Million
Q1 2018

May 11, 2018

SELL
$37.19 - $47.45 $515,081 - $657,182
-13,850 Reduced 19.8%
56,113 $7.83 Million
Q4 2017

Feb 15, 2018

BUY
$33.79 - $39.39 $21,084 - $24,579
624 Added 0.9%
69,963 $7.77 Million
Q3 2017

Nov 08, 2017

BUY
$36.29 - $38.83 $2.52 Million - $2.69 Million
69,339
69,339 $7.58 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.